Correlation Between Gilead Sciences and AC Immune

Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and AC Immune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and AC Immune into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Gilead Sciences and AC Immune, you can compare the effects of market volatilities on Gilead Sciences and AC Immune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of AC Immune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and AC Immune.

Diversification Opportunities for Gilead Sciences and AC Immune

-0.57

Correlation Coefficient

Gilead Sciences  AC Immune

Excellent diversification

The 3 months correlation between Gilead and ACIU is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and AC Immune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AC Immune and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with AC Immune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AC Immune has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and AC Immune go up and down completely randomly.

Pair Corralation between Gilead Sciences and AC Immune

Given the investment horizon of 90 days Gilead Sciences is expected to generate 1.42 times less return on investment than AC Immune. But when comparing it to its historical volatility, Gilead Sciences is 3.15 times less risky than AC Immune. It trades about 0.05 of its potential returns per unit of risk. AC Immune is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  269.00  in AC Immune on October 1, 2024 and sell it today you would earn a total of  4.00  from holding AC Immune or generate 1.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Gilead Sciences  vs.  AC Immune

Gilead Sciences

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating essential indicators, Gilead Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

AC Immune

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AC Immune has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Gilead Sciences and AC Immune

The main advantage of trading using opposite Gilead Sciences and AC Immune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, AC Immune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AC Immune will offset losses from the drop in AC Immune's long position.

The idea behind Gilead Sciences and AC Immune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.